Should we customize the treatment with interleukin‐17A inhibitors for moderate‐to‐severe psoriasis in the real‐world setting?

Kun Hu, Kun Hu Department of dermatology, Xiangya Hospital of Central South University, Changsha, China Search for more papers by this author Mi Zhang, Mi …

Den ganzen Artikel lesen

Folgen

Anmelden

Should we customize the treatment with interleukin‐17A inhibitors for moderate‐to‐severe psoriasis in the real‐world setting?

Table of Contents

Account

Navigation

Suche